Guidance A-Z — G
47 guidance documents beginning with G.
GaitSmart rehabilitation exercise programme for gait and mobility issues
Galaxy UNYCO for temporary stabilisation of lower limb fractures
Galcanezumab for preventing migraine
Gallstone disease
Gallstone disease: diagnosis and management
Gambling-related harms: identification, assessment and management
gammaCore for cluster headache
Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over
Garadacimab for preventing recurrent attacks of hereditary angioedema in people 12 years and over
Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
Gastro-oesophageal reflux disease in children and young people: diagnosis and management
Gastro-oesophageal reflux in children and young people
Gastroelectrical stimulation for gastroparesis
Gefapixant for treating refractory or unexplained chronic cough (terminated appraisal)
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer
Gemcitabine for the treatment of metastatic breast cancer
Gemtuzumab ozogamicin for untreated acute myeloid leukaemia
Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment
Generalised anxiety disorder and panic disorder in adults: management
Genicular artery embolisation for pain from knee osteoarthritis
Gilteritinib for treating relapsed or refractory acute myeloid leukaemia
Givinostat for treating Duchenne muscular dystrophy in people 6 years and over
Givosiran for treating acute hepatic porphyria
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal)
Glaucoma: diagnosis and management
Glecaprevir–pibrentasvir for treating chronic hepatitis C
Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments
Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse large B-cell lymphoma
Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosis
Golimumab for the treatment of psoriatic arthritis
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs
Golimumab for treating active non-radiographic axial spondyloarthritis
Gout: diagnosis and management
Granulox for managing chronic non-healing wounds
GreenLight XPS for treating benign prostatic hyperplasia
Grenz rays therapy for inflammatory skin conditions
Guidance on the use of coronary artery stents
Guidance on the use of electroconvulsive therapy
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes
Guidance on the use of imatinib for chronic myeloid leukaemia
Guidance on the use of paclitaxel in the treatment of ovarian cancer
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)
Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment
Guselkumab for previously treated moderately to severely active Crohn's disease
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs
Guselkumab for treating moderate to severe plaque psoriasis
Guselkumab for treating moderately to severely active ulcerative colitis
Galaxy UNYCO for temporary stabilisation of lower limb fractures
Galcanezumab for preventing migraine
Gallstone disease
Gallstone disease: diagnosis and management
Gambling-related harms: identification, assessment and management
gammaCore for cluster headache
Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over
Garadacimab for preventing recurrent attacks of hereditary angioedema in people 12 years and over
Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
Gastro-oesophageal reflux disease in children and young people: diagnosis and management
Gastro-oesophageal reflux in children and young people
Gastroelectrical stimulation for gastroparesis
Gefapixant for treating refractory or unexplained chronic cough (terminated appraisal)
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer
Gemcitabine for the treatment of metastatic breast cancer
Gemtuzumab ozogamicin for untreated acute myeloid leukaemia
Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment
Generalised anxiety disorder and panic disorder in adults: management
Genicular artery embolisation for pain from knee osteoarthritis
Gilteritinib for treating relapsed or refractory acute myeloid leukaemia
Givinostat for treating Duchenne muscular dystrophy in people 6 years and over
Givosiran for treating acute hepatic porphyria
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal)
Glaucoma: diagnosis and management
Glecaprevir–pibrentasvir for treating chronic hepatitis C
Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments
Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse large B-cell lymphoma
Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosis
Golimumab for the treatment of psoriatic arthritis
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs
Golimumab for treating active non-radiographic axial spondyloarthritis
Gout: diagnosis and management
Granulox for managing chronic non-healing wounds
GreenLight XPS for treating benign prostatic hyperplasia
Grenz rays therapy for inflammatory skin conditions
Guidance on the use of coronary artery stents
Guidance on the use of electroconvulsive therapy
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes
Guidance on the use of imatinib for chronic myeloid leukaemia
Guidance on the use of paclitaxel in the treatment of ovarian cancer
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)
Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment
Guselkumab for previously treated moderately to severely active Crohn's disease
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs
Guselkumab for treating moderate to severe plaque psoriasis
Guselkumab for treating moderately to severely active ulcerative colitis